论文部分内容阅读
1 材料和方法 全部患者均为口服甲胺磷中、重度中毒病人,随机分为二组,新疗法组和传统疗法组。新疗法组和传统疗法组各31例,新疗法组中度中毒5例,重度中毒26例;传统疗法组中度中毒6例,重度中毒25例。中毒程度两组无差异,有可比性。 新疗法中度中毒病人入院后立即给复方解磷注液射2～4ml肌注,同时给予阿托品.5～10mg皮下注射,重度中毒病人给予复方解磷注射液4～6ml,阿托品10～30mg同时给予洗胃,维持呼吸,循环功能等综合治疗措施。
1 Materials and Methods All patients were oral methamidophos, severe poisoning patients were randomly divided into two groups, the new therapy group and the traditional therapy group. The new therapy group and the traditional therapy group each 31 cases, the new therapy group moderate poisoning in 5 cases, severe poisoning in 26 cases; the traditional therapy group moderate poisoning in 6 cases, severe poisoning in 25 cases. Degree of poisoning no difference between the two groups, comparable. New treatment moderate poisoning patients immediately after admission to the compound solution of phosgene injection of 2 ~ 4ml intramuscular injection, while giving atropine .5 ~ 10mg subcutaneous injection, severe poisoning patients given compound Phosphate injection 4 ~ 6ml, atropine 10 ~ 30mg at the same time To gastric lavage, maintain breathing, circulation and other comprehensive treatment measures.